These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23112083)

  • 1. A cell-based high-throughput screening assay for posttranscriptional utrophin upregulation.
    Moorwood C; Soni N; Patel G; Wilton SD; Khurana TS
    J Biomol Screen; 2013 Apr; 18(4):400-6. PubMed ID: 23112083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening.
    Moorwood C; Lozynska O; Suri N; Napper AD; Diamond SL; Khurana TS
    PLoS One; 2011; 6(10):e26169. PubMed ID: 22028826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duchenne muscular dystrophy drug discovery - the application of utrophin promoter activation screening.
    Moorwood C; Khurana TS
    Expert Opin Drug Discov; 2013 May; 8(5):569-81. PubMed ID: 23473647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
    Miura P; Jasmin BJ
    Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utrophin upregulation in Duchenne muscular dystrophy.
    Hirst RC; McCullagh KJ; Davies KE
    Acta Myol; 2005 Dec; 24(3):209-16. PubMed ID: 16629055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cis-Acting Sequence Elements and Upstream Open Reading Frame in Mouse Utrophin-A 5'-UTR Repress Cap-Dependent Translation.
    Ghosh T; Basu U
    PLoS One; 2015; 10(7):e0134809. PubMed ID: 26230628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine.
    Takahashi J; Itoh Y; Fujimori K; Imamura M; Wakayama Y; Miyagoe-Suzuki Y; Takeda S
    J Gene Med; 2005 Feb; 7(2):237-48. PubMed ID: 15538725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput identification of post-transcriptional utrophin up-regulators for Duchenne muscle dystrophy (DMD) therapy.
    Loro E; Sengupta K; Bogdanovich S; Whig K; Schultz DC; Huryn DM; Khurana TS
    Sci Rep; 2020 Feb; 10(1):2132. PubMed ID: 32034254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational regulation of utrophin by miRNAs.
    Basu U; Lozynska O; Moorwood C; Patel G; Wilton SD; Khurana TS
    PLoS One; 2011; 6(12):e29376. PubMed ID: 22216264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice.
    Perronnet C; Chagneau C; Le Blanc P; Samson-Desvignes N; Mornet D; Laroche S; De La Porte S; Vaillend C
    Hum Mol Genet; 2012 May; 21(10):2263-76. PubMed ID: 22343141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and functional significance of utrophin expression at the mammalian neuromuscular synapse.
    Gramolini AO; Wu J; Jasmin BJ
    Microsc Res Tech; 2000 Apr; 49(1):90-100. PubMed ID: 10757882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.
    Tinsley JM; Potter AC; Phelps SR; Fisher R; Trickett JI; Davies KE
    Nature; 1996 Nov; 384(6607):349-53. PubMed ID: 8934518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy.
    Burton EA; Tinsley JM; Holzfeind PJ; Rodrigues NR; Davies KE
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14025-30. PubMed ID: 10570192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy.
    Krag TO; Gyrd-Hansen M; Khurana TS
    Acta Physiol Scand; 2001 Mar; 171(3):349-58. PubMed ID: 11412148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utrophin A 5'-UTR drives cap-independent translation exclusively in skeletal muscles of transgenic mice and interacts with eEF1A2.
    Miura P; Coriati A; Bélanger G; De Repentigny Y; Lee J; Kothary R; Holcik M; Jasmin BJ
    Hum Mol Genet; 2010 Apr; 19(7):1211-20. PubMed ID: 20053670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
    Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
    Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of therapeutics that target eEF1A2 and upregulate utrophin A translation in dystrophic muscles.
    Péladeau C; Adam N; Bronicki LM; Coriati A; Thabet M; Al-Rewashdy H; Vanstone J; Mears A; Renaud JM; Holcik M; Jasmin BJ
    Nat Commun; 2020 Apr; 11(1):1990. PubMed ID: 32332749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle.
    Tanihata J; Suzuki N; Miyagoe-Suzuki Y; Imaizumi K; Takeda S
    J Gene Med; 2008 Jun; 10(6):702-13. PubMed ID: 18338831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttranscriptional regulation of acute phase serum amyloid A2 expression by the 5'- and 3'-untranslated regions of its mRNA.
    Longley DB; Steel DM; Whitehead AS
    J Immunol; 1999 Oct; 163(8):4537-45. PubMed ID: 10510397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy.
    Chaubourt E; Fossier P; Baux G; Leprince C; Israël M; De La Porte S
    Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.